Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients

Source: www.breitbart.com · Section: politics · Bias: Right · Published: Wed, 16 Sep 2026 11:50:09 GMT

A newly released observational analysis found that 84.4% of cancer patients treated off-label with a compounded combination of Ivermectin and Mebendazole experienced a clinical benefit. The post Ivermectin + Mebendazole: Groundbreaking Study Reports 84.4% Clinical Benefit Rate in Cancer Patients appeared first on Breitbart.

Read the full article at www.breitbart.com →

The same story across the political spectrum (15 sources)

Center: 'I can get more time - that's everything': Breast cancer patients get life-extending drug — www.bbc.com
Right: Detroit News Endorses Mike Rogers as ‘Clearly the Best Choice’ for U.S. Senate in Michigan — www.breitbart.com
Right: Trump Says Interest Rates Should Be 1% or Less After Fed's First Hike in 3 Years — www.breitbart.com
Right: Trump: Iran ‘Very Much’ Wants a Deal, Reached Out ‘Directly’ — ‘Hopefully’ Nearing End of War — www.breitbart.com
Right: Kamala Harris to Stump in Michigan with Socialist Abdul El-Sayed — www.breitbart.com

← Back to FlashTopics.com